MAS
MASCO CORP /DE/Evidence as of 2026-09-03Overview · MASCO CORP /DE/
Masco Corporation designs, manufactures, and distributes home improvement and building products in North America, Europe, and internationally. The company's Plumbing Products segment offers faucets, showerheads, handheld showers, valves, bath hardware and accessories, bathing units, shower bases and enclosures, sinks, toilets, acrylic tubs, shower trays, spas, exercise pools, and fitness systems; brass, copper, and c…
Management team
- Mr. Zack Gordon · President of Masco VenturesFind on LinkedIn
- Ms. Sue Sabo · Director of Corporate CommunicationsFind on LinkedIn
- Mr. Imran Ahmad · Group President of Decorative Architectural ProductsFind on LinkedIn
- Mr. Kenneth G. Cole J.D. · VP, General Counsel & SecretaryFind on LinkedIn
Start your 7-day free trial to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
Moneyta sentiment
Where the published evidence leans after the desk debated it — not a rating or a recommendation.
+0.1 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled — the rest of the page is the evidence behind it.
The evidence balance is Mixed (+0.1 of a possible +2; was +0.1 before debate) · confidence high. Revenue rose from $ 1,801,000,000 in fiscal Q1 2025 (fiscal quarter ended 2025-03-31) to $ 1,918,000,000 in fiscal Q1 2026 (fiscal quarter ended 2026-03-31), an increase of $ 117,000,000. Gross profit was $ 644,000,000 in fiscal Q1 2025 and $ 686,000,000 in fiscal Q1 2026, producing essentially stable gross‑profit‑to‑revenue ratios of about 35.8% in both quarters by simple division of the reported figures.
Operating income was $ 286,000,000 in fiscal Q1 2025 and $ 316,000,000 in fiscal Q1 2026, with mid‑2025 quarters showing $ 412,000,000 (fiscal Q2 2025, ended 2025-06-30) and $ 303,000,000 (fiscal Q3 2025, ended 2025-09-30). Diluted EPS rose from $ 0.87 to $ 1.05 year over year for those same Q1 periods. Reported shares outstanding declined from 211,983,493 as of 2025-01-31 to 201,734,437 as of 2026-03-31, while repurchase cash use increased from $ 130,000,000 to $ 202,000,000 in the comparable early‑year quarters; operating cash flow in those quarters was negative $ 158,000,000 and negative $ 79,000,000, respectively.
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.
Revenue for the quarter 2025-01-01 to 2025-03-31 (fiscal Q1 2025) was $1,801,000,000 and for the quarter 2026-01-01 to 2026-03-31 (fiscal Q1 2026, ended 31 March 2026) was $1,918,000,000 (a year-over-year increase of $117,000,000).
XBRL companyfacts · 0000062996-25-000010Gross profit was $644,000,000 in fiscal Q1 2025 (2025-01-01 to 2025-03-31) and $686,000,000 in fiscal Q1 2026 (2026-01-01 to 2026-03-31), producing essentially stable gross-profit-to-revenue ratios (about 35.8% in Q1 2025 and roughly 35.8% in Q1 2026 by simple division of those reported figures).
XBRL companyfacts · 0000062996-26-000014Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Nothing in this slice of the evidence rose to a claim — a quiet read, which itself is information.
Which filings the desk reads
The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.
Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.
No computed signal history for this symbol yet — signals need roughly 70 trading days of price history.
Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
As of 2026-09-02T13:45:47.228469+00:00, MAS is a holding in the ETF with symbol IVV at a weight of 0.03% of that fund.
ETF constituents · market dataThe 0.03% weight indicates MAS represents a very small share of the IVV portfolio as reported on 2026-09-02T13:45:47.228469+00:00.
ETF constituents · market dataReads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
In its recently reported second-quarter 2026 results, Masco posted higher adjusted earnings that exceeded forecasts while net sales declined.
News · simplywall.st · 2026-08-30Masco said it lifted its 2026 adjusted earnings outlook driven largely by expected tariff refunds, per its second-quarter 2026 report.
News · simplywall.st · 2026-08-30Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
No insider transactions on file in the trailing 180 days.
Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The trailing twelve-month price-to-earnings ratio is 17.3, based on EPS of 4.1 and a price of 70.94 as of 2026-09-02.
Valuation inputs · SEC XBRL + stored EOD closeEnterprise value to trailing twelve-month EBITDA is 11.52, with EBITDA (TTM) of 1,464,000,000 and enterprise value of 16,870,040,961.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.
Several company-specific data points and recent news jointly support a favorable read: Masco shows year-over-year revenue growth in fiscal Q1 2026, higher diluted EPS over the same period, shrinking share count with meaningful repurchases, and positive operating income/EBITDA on a trailing basis. Recent second-quarter reporting and filings cite higher adjusted earnings, an upgraded earnings outlook tied to tariff refunds, large shareholder returns in the quarter, and fresh institutional buying, which together indicate improving operational profitability and investor interest despite near-term cash-flow noise. Valuation metrics such as a trailing P/E of 17.3 and positive EBITDA suggest the market is pricing in ongoing earnings capacity rather than only balance-sheet weakness. While balance-sheet and free-cash-flow metrics raise caution, the combination of rising reported earnings, buybacks, and institutional accumulation provides a cohesive set of signals that support a favorable interpretation of the company’s recent performance.
Chair's verdict, claim by claim
Fragility · computed, not argued
balanced0.38
22 surviving claims rest on 10 distinct sources; the heaviest analyst carries 36% of them, and 100% of what the desk raised survived the debate.
The set of 22 surviving claims draws on 10 distinct sources, but a single analyst accounts for over one-third of the claims and every point the desk raised survived the internal debate. That concentration and unanimous survival increase the influence of a few inputs — informative but relatively fragile; readers should give these conclusions cautious weight and look for independent corroboration before treating them as robust.
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.
11 filings· 2 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.
Read by Mercer+0.3 to the score
1 holdings record
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.0 to the score
7 headlines· 1 cited
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
1 record· 0 cited
Analyst consensus
Third-party consensus, shown for context only — it never enters Moneyta sentiment.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
Get this for the tickers you actually hold
Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.
The full terminal on MAS Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.